Literature DB >> 22683347

Inorganic arsenic impairs proliferation and cytokine expression in human primary T lymphocytes.

Claudie Morzadec1, Fidaa Bouezzedine, Mélinda Macoch, Olivier Fardel, Laurent Vernhet.   

Abstract

Inorganic arsenic is a toxic environmental contaminant to which humans are mainly exposed through drinking water. This metalloid impairs functions of several key immune cells. Particularly, it reduces IL-2 secretion and proliferation of blood peripheral mononuclear cells stimulated by lectins that, however, do not mimic physiological T cell activation. The present study used isolated human T cells activated, in a more physiological manner, through stimulation with CD3/CD28 antibodies, to carefully analyze the impact of arsenic on T cell proliferation and cytokine expression. We demonstrate that non cytotoxic concentrations of sodium arsenite (As(III), 0.25-2μM) significantly reduce T cell proliferation by increasing the percentage of non dividing cells blocked in G1 phase and by preventing cyclin D3 and CDC25A expression. They also markedly, although not totally, reduces IL-2 expression at both mRNA and protein levels; however, metalloid-dependent inhibition of T cells could not be reversed by addition of recombinant IL-2. In addition, As(III) markedly reduces secretion of interferon-γ without impairing that of IL-4 and IL-13; it also decreases interferon-γ mRNA levels but increases those of IL-13. Finally, simultaneously to its immune effects, As(III) rapidly and potently increases expression of the redox-sensitive genes HMOX1, NQO1 and GCLM in activated T cells without altering the levels of reactive oxygen species. In conclusion, our results demonstrate that As(III) inhibits T cell proliferation, independently of IL-2, and alters the Th balance of cytokines secreted by co-stimulated T cells which thus constitute direct targets of this major environmental contaminant.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683347     DOI: 10.1016/j.tox.2012.05.025

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  23 in total

Review 1.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

2.  High soil and groundwater arsenic levels induce high body arsenic loads, health risk and potential anemia for inhabitants of northeastern Iran.

Authors:  Masumeh Taheri; Jalil Mehrzad; Mohamad Hosein Mahmudy Gharaie; Reza Afshari; Ahmad Dadsetan; Shakiba Hami
Journal:  Environ Geochem Health       Date:  2015-06-23       Impact factor: 4.609

Review 3.  Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex.

Authors:  Daniele Ferrario; Laura Gribaldo; Thomas Hartung
Journal:  Curr Environ Health Rep       Date:  2016-03

4.  Grape seed proanthocyanidin extract alleviates arsenic-induced lung damage through NF-κB signaling.

Authors:  Yunhua Hu; Meng Wei; Qiang Niu; Rulin Ma; Yu Li; Xianhua Wang; Gangling Feng; Shugang Li; Lijuan Pang
Journal:  Exp Biol Med (Maywood)       Date:  2019-03

Review 5.  Mechanistic understanding of the toxic effects of arsenic and warfare arsenicals on human health and environment.

Authors:  Suhail Muzaffar; Jasim Khan; Ritesh Srivastava; Marina S Gorbatyuk; Mohammad Athar
Journal:  Cell Biol Toxicol       Date:  2022-04-01       Impact factor: 6.691

Review 6.  Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.

Authors:  Pablo Pánico; Myrian Velasco; Ana María Salazar; Arturo Picones; Rosa Isela Ortiz-Huidobro; Gabriela Guerrero-Palomo; Manuel Eduardo Salgado-Bernabé; Patricia Ostrosky-Wegman; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

7.  Arsenic exposure and cell-mediated immunity in pre-school children in rural Bangladesh.

Authors:  Sultan Ahmed; Sophie E Moore; Maria Kippler; Renee Gardner; M D H Hawlader; Yukiko Wagatsuma; Rubhana Raqib; Marie Vahter
Journal:  Toxicol Sci       Date:  2014-06-12       Impact factor: 4.849

8.  Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.

Authors:  Jacob L Glass; Andriy Derkach; Patrick Hilden; Amber King; Susan K Seo; Katya Ahr; Ashwin Kishtagari; Ross L Levine; Martin S Tallman; Dan Douer
Journal:  Leuk Res       Date:  2021-03-31       Impact factor: 3.715

9.  Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo.

Authors:  Peace C Ezeh; Fredine T Lauer; Debra MacKenzie; Shea McClain; Ke Jian Liu; Laurie G Hudson; A Jay Gandolfi; Scott W Burchiel
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem.

Authors:  Marisa F Naujokas; Beth Anderson; Habibul Ahsan; H Vasken Aposhian; Joseph H Graziano; Claudia Thompson; William A Suk
Journal:  Environ Health Perspect       Date:  2013-01-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.